iMaps ETIs

iMaps ETIs

An investment in the iMaps ETIs listed below involves risks, including possible loss of principal, and may not be suitable for all investors. Clicking on the product name leads to the detail page with further information.

ETI Securities issued by iMaps ETI AG are issued under the up to EUR 27,182,818,285 Programme for the issue of ETI Securities in the form of derivative securities arranged by iMaps Capital Markets SEZC as a public offering.

The base prospectus got approved by FMA Liechtenstein and is available for download here:


Scroll to Top

iMaps Capital Disclaimer

In order to view the information relating to the Products section of our website (, you must accept the terms and conditions set out below, and our separate Terms of use. If you do not agree to these Terms, you will only be able to view information relating to those ETI’s which are publicly offered. By clicking “I Accept” below and accessing the information and material available on the Website, you accept these Terms. The website and the information contained herein is not intended to be a source of investment advice or credit analysis with respect to the material and/or presented. The material presented to you in this website is not and should not be considered as an offer, invitation or recommendation to sell or a solicitation of an offer to buy any of the securities in any jurisdiction. The information provided does not take into account your particular investment objectives, financial situation or needs. Before acting on any information you should consider the appropriateness of the information having regard to these matters.

I confirm that

  • I have read and accept the Terms and Conditions of using this website, detailed above;
  • I am a sopisticated investor
  • I will not make an investment in an investment Product, or advise another to do so, if the promotion of the investment Product to the type of investor I represent is prohibited;
  • I recognise that the information provided on this website is for information purposes only and is not a solicitation of an investment;
  • I will study the prospectus, KIID or Offering Memorandum of an Investment Product, including the risk factors before making an investment.